| 0069-0305 |
Trazimera |
trastuzumab-qyyp |
Pfizer Laboratories Div Pfizer Inc |
KIT |
|
2020-02-24 |
| 0069-0308 |
Trazimera |
trastuzumab-qyyp |
Pfizer Laboratories Div Pfizer Inc |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2021-03-10 |
| 0597-9257 |
HERNEXEOS |
zongertinib |
Boehringer Ingelheim Pharmaceuticals, Inc. |
TABLET, FILM COATED |
|
2025-08-08 |
| 50242-077 |
Herceptin Hylecta |
Trastuzumab and hyaluronidase-oysk |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2019-02-28 |
| 50242-132 |
Herceptin |
Trastuzumab |
Genentech, Inc. |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2017-02-10 |
| 50242-145 |
PERJETA |
Pertuzumab |
Genentech, Inc. |
INJECTION, SOLUTION, CONCENTRATE |
|
2012-06-08 |
| 50242-245 |
Phesgo |
pertuzumab, trastuzumab, and hyaluronidase-zzxf |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2020-06-29 |
| 50242-260 |
Phesgo |
pertuzumab, trastuzumab, and hyaluronidase-zzxf |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2020-06-29 |
| 55513-132 |
Kanjinti |
trastuzumab-anns |
Amgen, Inc |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2019-06-11 |
| 55513-141 |
Kanjinti |
trastuzumab-anns |
Amgen, Inc |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2019-10-28 |
| 63459-303 |
HERZUMA |
TRASTUZUMAB |
Cephalon, Inc. |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2020-03-16 |
| 63459-305 |
HERZUMA |
TRASTUZUMAB |
Cephalon, Inc. |
KIT |
|
2020-03-16 |
| 69448-015 |
HERCESSI |
trastuzumab-strf |
Accord BioPharma Inc. |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2025-01-01 |
| 69448-016 |
HERCESSI |
trastuzumab-strf |
Accord BioPharma Inc. |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2025-01-01 |
| 70720-022 |
MARGENZA |
margetuximab-cmkb |
TerSera Therapeutics LLC |
INJECTION, SOLUTION, CONCENTRATE |
|
2021-01-15 |
| 74527-022 |
MARGENZA |
margetuximab-cmkb |
MacroGenics, Inc |
INJECTION, SOLUTION, CONCENTRATE |
|
2021-01-15 |
| 78206-147 |
Ontruzant |
trastuzumab |
Organon LLC |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2021-06-01 |
| 78206-148 |
Ontruzant |
Ontruzant |
Organon LLC |
KIT |
|
2021-06-01 |
| 83257-001 |
OGIVRI |
trastuzumab-dkst |
Biocon Biologics Inc. |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2023-10-01 |
| 83257-003 |
OGIVRI |
trastuzumab-dkst |
Biocon Biologics Inc. |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|
2023-10-01 |
| 83257-004 |
OGIVRI |
trastuzumab-dkst |
Biocon Biologics Inc. |
KIT |
|
2023-10-01 |